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1. Introduction 
Embryonic stem (ES) cells have generated enormous interest because of their capacity to 
self-renew and differentiate into various cell types in vitro. Although numerous problems 
are encountered in the use of ES cells for regenerative medicine, such as ethical issues 
associated with the use of stem cells established from terminated human embryos and 
immunorejection due to transplantation of allogenic ES cell-derived cells into patients, 
recent technologies to generate induced pluripotent stem (iPS) cells from adult somatic 
cells have provided alternative ways to access pluripotent stem cells (Takahashi et al., 
2007). However, the practical application of these pluripotent stem cells has yet to emerge, 
and regulatory mechanisms are not well known. Moreover, precise differentiation 
methodologies of ES and iPS cells have not been developed. These problems cause 
difficulties in the manipulation of pluripotent stem cells and derivation of functionally 
differentiated cells. Detailed analysis of the transcriptome has allowed elucidation of 
transcription networks that regulate the pluripotency of these stem cells. However, the 
specific nuclear infrastructures that maintain the pluripotent stem cell-specific 
transcription network have not yet been elucidated. We used proteomics to analyze the 
nuclear protein machinery in stem cells and identified some crucial components for the 
maintenance of pluripotent stem cells. In addition, various growth factors and 
extracellular matrix components regulate the pluripotency and differentiation of stem 
cells. Therefore, the cell surface receptors that bind these regulatory factors are important 
for the precise regulation of stem cells. We have also explored stem cell-specific cell-
surface markers by proteomic analysis of mouse ES cells. These cell-surface membrane 
proteins can be useful to manipulate pluripotent stem cells. In this chapter, we describe 
some examples of new findings elucidated by proteomic analysis of ES cells. 
2. Quantitative analysis of proteins by proteomics 
To identify proteins from complex samples, there are three major approaches (Fig. 1). One is 
a 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE)-based method, and the 
other two are shotgun-based methods using 2D-liquid chromatography (2D-LC). The first 
approach, which involves 2D-gel electrophoresis followed by identification of isolated 
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proteins by mass spectrometry (MS), has been used for a long time. To obtain comparative 
data of two different samples, 2-dimensional difference gel electrophoresis (2D-DIGE) has 
been developed (Unlu, et al., 1997). In this method, protein samples that are covalently 
conjugated with different fluorescent dyes are combined, resolved by 2D-PAGE, and 
differentially expressed protein spots are quantified according to the intensity of each 
fluorescent color by a laser scanner. Differentially expressed protein spots are then excised 
from the gel, trypsinized, and subjected to MS analysis. To identify the proteins, molecular 
weight information of the digested peptides are compared with databases such as the 
National Center for Biotechnology Information (NCBI) and Swiss-Prot. 
In contrast, in the case of the shotgun-based methods, protein samples are first digested 
with a specific protease, and the resulting huge number of peptides are fractionated by 2D-
capillary chromatography followed by automated analysis by MS (Nagele, et al., 2004, Wu, 
et al., 2006). For quantitative analysis by the shotgun method, isobaric tag for relative and 
absolute quantitation (iTRAQ) have recently been developed as a labeling reagent for the 
digested peptide fragments (Ross, et al., 2004). During tandem mass spectrometric (MS/MS) 
analysis, the isobaric tags are readily cleaved from the peptides, and the generated reporter 
fragments from different samples give different molecular weight peaks. By comparing the 
intensity of these reporter fragments, the relative protein quantity of each protein sample 
can be calculated. In contrast, peptide fragments without reporters are used to identify 
peptide sequence by MS/MS analysis. Alternatively, SILAC (stable isotope labeling with 
amino acids in culture) can be used when comparing proteins in cells cultured under 
different conditions, such as with or without growth factors, chemicals, or at different time 
points. In this case, cells are cultured in normal medium or medium replaced with selected 
amino acids synthesized with 13C and 15N (Chen, et al., 2000, Ong, et al., 2002). Under these 
conditions, the labeled “heavy” amino acid will be incorporated into most of the proteins in 
the cell. After harvesting, these labeled and non-labeled cells are combined and processed as 
the normal shotgun method without labeling. Quantification of proteins can be done by 
comparing the intensity of light and heavy MS peaks of each peptide. In the present study, 
we applied quantitative proteomics to identify critical proteins in regulating the 
pluripotency-specific transcription network. 
3. Proteomic analysis of pluripotency-specific nuclear proteins expressed in 
mouse embryonic stem cells 
To identify specific proteins involved in the regulation of pluripotent stem cells, we used 
mouse ES cells. Although mouse ES cells are normally cultured on mouse embryonic 
fibroblast feeder cells, some mouse ES cell lines, such as D3 cells, can be maintained without 
feeder cells. We used D3 cell line for our analysis to avoid contamination of feeder cells. 
Leukemia inhibitory factor (LIF) is a crucial factor for maintenance of undifferentiated 
mouse ES cells. Culturing ES cells without LIF on a gelatin-coated dish for 7 days induces 
spontaneous differentiation. These pluripotent ES cells and the differentiated cells cultured 
without LIF were disrupted in a hypotonic buffer, centrifuged, and nuclear and cytoplasmic 
fractions were prepared. Proteins in these fractions were analyzed by 2D-DIGE. Proteins 
prepared from pluripotent cells or differentiated cells were labeled with different 
fluorescent dyes, separated by 2D-PAGE, and expression of the resolved protein spots were 
quantitatively analyzed by scanning the fluorescent intensity of the labeled protein spots. 
Differentially expressed protein spots were extracted and identified by MS (Fig. 2). More 
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Fig. 1. Three major approaches for quantitative proteomic analysis.  
(A) 2D-DIGE is a 2D-PAGE-based method using fluorescently labeled protein samples. 
Quantification of protein expression is performed on a 2D-PAGE gel and differentially 
expressed proteins are further analyzed by MS. (B) 2D-LC method with iTRAQ reagents. 
Protein samples are first digested with a protease and then labeled with isobaric tag 
reagents. Labeled peptide samples are mixed, fractionated by 2D-LC, and analyzed by 
MS/MS. Quantification is based on the relative intensity of the reporter fragments of iTRAQ 
reagents. (C) 2D-LC method with metabolically labeled samples. Cells are cultured with 
isobaric amino acids, and harvested cells are combined and processed as in (B) without the 
labeling step. Quantification of proteins is based on the intensity of each MS peak. 
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Fig. 2. Proteomic analysis of pluripotency-specific proteins expressed in mouse ES cells. 
Mouse ES cells cultured with or without LIF for one week were used as the source of 
pluripotent ES cells and differentiated cells, respectively. Pluripotent ES cells showed 
alkaline phosphatase activity and were positive for Oct4 and SSEA-1. In contrast, the 
differentiated cells were negative for these markers. The extracted proteins were labeled 
with green or red fluorescent dyes, mixed, and analyzed by 2D-DIGE.  
than 100 proteins specifically expressed in pluripotent ES cells were identified from nuclear 
and cytoplasmic extracts. This study was the first detailed proteomic analysis of 
pluripotency-specific nuclear proteins in mouse ES cells (Kurisaki, et al., 2005).  
Interestingly, many of the pluripotent stem cell-specific nuclear proteins were related to 
chromatin functions. For example, we identified the 60-kDa subunit of the SWI/SNF complex 
(BAF60a/Smarcd1), a component of a chromatin-remodeling complex, which slides 
nucleosomes along the DNA helix in an ATP-dependent manner and functions to expose 
genomic DNA to transcription factors or chromatin modifiers (Roberts, et al., 2004). We also 
identified one of the high-mobility group proteins (HMG-B2), which loosens the DNA helix 
thereby enhancing the accessibility to chromatin-remodeling complexes and possibly to 
transcription factors (Travers, 2003). Amine oxidase flavin-containing domain protein 2 
(AOF2), also known as lysine-specific demethylase 1 (LSD1), is a demethylase for histone 
H3K4. Methylation of histone H3K4 is linked to active transcription. A recent report indicated 
that LSD1 regulates the expression and appropriate timing of key developmental regulators 
during early embryonic development (Foster, et al., 2010). Transcriptional intermediary factor 
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1┚ (TIF1┚/KAP1/Trim28) has been reported to be a universal corepressor that forms a 
complex with histone methyltransferase SETDB1, which methylates histone H3K9 within 
euchromatin (Ivanov, et al., 2007, Sripathy, et al., 2006). RbAp48 is a histone-binding protein, 
which is often found in various histone modifying enzyme complexes (Wolffe, et al., 2000). 
MSH2 is a DNA mismatch repair protein, and recent reports have suggested that this protein 
could function as a coactivator of transcription (Wada-Hiraike, et al., 2005).  
In the same year, a large proteomic dataset of proteins expressed in the E14 mouse ES cell 
line was analyzed by 2D-LC-based proteomics (Nagano, et al., 2005). Although the 
expression of the identified proteins was not systematically compared with other non-ES 
cells or differentiated cells, 1790 proteins in total were identified, including 365 potential 
nuclear proteins, such as pluripotency-specific transcription factors Oct4 and Sox2, as well 
as chromatin-related proteins TIF1┚ and Smarcd1. Very recently, another group has 
performed extensive proteomic analysis using ES-like embryonic carcinoma cells (F9) and 
differentiated cells (NIH3T3), and identified a number of chromatin-remodeling factors 
highly expressed in F9 cells (Singhal, et al., 2010).  
4. TIF1β regulates the pluripotency of embryonic stem cells 
To isolate crucial regulatory components for the maintenance of ES cell pluripotency, the 
proteins identified by MS analysis were stably expressed in ES cells and further functional 
screening was performed according to their prolonged alkaline phosphatase activity in the 
absence of LIF. Among these chromatin-related proteins, we found TIF1┚ as a functional 
regulator of pluripotency, which prolonged the pluripotency of ES cells after withdrawal of 
LIF. Recently, other groups have also identified TIF1┚ as an essential gene for mouse ES 
cells by RNAi-based screening (Fazzio, et al., 2008, Hu, et al., 2009). However, the 
mechanism by which TIF1┚ regulates ES cell pluripotency has not been well elucidated.  
When TIF1┚ was knocked down in mouse ES cells, the cells lost their tight, compact 
morphology and adopted a stretched-out shape even in the presence of LIF. The growth of 
TIF1┚-knockdown ES cells was significantly decreased, and the expression of pluripotency 
markers SSEA1 and Nanog was diminished. In contrast, expression of the primitive 
ectoderm marker gene, Fgf5, and relatively weak expression of the extraembryonic 
ectoderm marker gene, Eomes, was induced. These results indicate that TIF1┚ is an 
indispensable factor for the maintenance of pluripotency in ES cells, which preferentially 
inhibits the differentiation of ES cells into primitive ectoderm cells. 
When we carefully analyzed the expression of TIF1┚ in ES cells, we found that TIF1┚ is 
specifically phosphorylated at serine 824 (S824), which induces active relaxation of 
chromatin (Ziv, et al., 2006). Phosphorylation at S824 was dramatically decreased when the 
cells were differentiated. As shown in Fig. 3, TIF1┚ was highly phosphorylated in the inner 
cell mass of embryos during early development, from which ES cells can be established 
(Seki et al., 2010). Ataxia telangiectasia mutated (ATM), a serine/threonine protein kinase, 
has been reported to be a specific kinase for S824 of TIF1┚ upon DNA double-strand 
breakage (Ziv, et al., 2006). We confirmed that ATM could phosphorylate the C-terminus of 
TIF1┚ as transfection of ATM shRNA significantly decreased the phosphorylation of TIF1┚. 
Concomitantly, protein levels of Oct4 and Nanog were also decreased by knockdown of 
ATM in mouse ES cells, further supporting the importance of TIF1 ┚ phosphorylation.  
Unexpectedly, TIF1┚ had distinct effects on ES cells in a phosphorylation-dependent 
manner. First, phosphorylated TIF1┚ promotes the pluripotency of mouse ES cells. Stable  
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Fig. 3. Specific localization of phosphorylated TIF1┚ in mouse embryos. Mouse embryos 
(E3.5) were immunostained with TIF1┚ (red) and phosphorylated TIF1┚ (green) antibodies. 
Phosphorylated TIF1┚ is highly concentrated in the inner cell mass of blastocysts (quoted 
from Seki et al., 2010). 
expression of the TIF1┚-S824D mutant, which mimics phosphorylated TIF1┚ and induces 
constitutive chromatin relaxation, maintained Oct4 and Nanog protein expression after 8 
days in culture without LIF. In contrast, expression of TIF1┚-S824A, which cannot be 
phosphoryated, in ES cells did not show these effects. Second, TIF1┚ inhibits the 
differentiation of mouse ES cells in a C-terminal phosphorylation-dependent manner. 
Embryoid bodies prepared from dissociated ES cells were cultured in suspension in serum-
free medium and then differentiated by adhesion culture on a poly-L-lysine, laminin, and 
fibronectin coated dish. Although the cells transfected with the control vector and TIF1┚-
S824A–expressing cells showed significant outgrowth of neurofilament-200- and TuJ1-
positive neurites projected from embryoid bodies, TIF1┚-S824D-expressing cells did not 
show such outgrowth. Third, phosphorylation of TIF1┚ is important for induction of iPS 
cells from somatic cells. Retroviral gene transfer of TIF1┚-S824A dramatically decreased the 
generation of ES-like colonies from mouse embryonic fibroblasts infected with four 
transcription factors, Oct4, Sox2, Klf4, and c-Myc. Moreover, the colonies were very difficult 
to establish as iPS cell lines, and ES cell-specific markers were not expressed in these cells. In 
contrast, the induction of iPS cells was increased when TIF1┚-S824D was introduced in 
addition to the above four transcription factors. Interstingly, the induced iPS cells generated 
with TIF1┚-S824D showed more complete expression of ES cell-specific marker genes. The 
phosphorylation of TIF1┚, which induces relaxation of chromatin, seems to affect the 
efficiency of iPS induction and the quality of established clones of iPS cells. 
TIF1┚ has been reported to be involved in transcriptional repression with heterochromatin 
protein 1 (HP1) and localized to heterochromatin foci in differentiated cells (Sripathy, et al., 
2006). However, in pluripotent ES cells, TIF1┚ is diffusely localized in the nucleoplasm and 
is not localized with heterochromatin foci. On the other hand, phosphorylated TIF1┚ (S824) 
showed punctate staining in the nucleus. This characteristic localization of phosphorylated 
TIF1┚ was partially colocalized with transcriptionally activated euchromatin markers such 
as histone H3K4me3 and H3K9Ac, but not with the heterochromatin markers histone 
H3K9me3 and HP1┙. These data suggest that TIF1┚ could play a distinct role in pluripotent 
ES cells as compared to other differentiated cells. 
www.intechopen.com
Proteomic Analysis of Mouse ES Cells   
 
149 
What is the function of phosphorylated TIF1┚ in the specific nuclear spots? We 
hypothesized that phosphorylated TIF1┚ might be involved in transcriptional activation of 
pluripotency-specific genes in the activated chromatin foci of pluripotent stem cells. In fact, 
ectopic expression of TIF1┚-S824D, but not TIF1┚-S824A, in ES cells markedly induced 
various pluripotency-specific genes such as Nanog, Sox2, and Dax1. Moreover, knockdown 
of TIF1┚ resulted in an increased number of H3K9me3 and HP1┙ foci, suggesting that 
endogenous TIF1┚ inhibits H3K9me3 and HP1┙ foci formation in pluripotent mouse ES 
cells. These results suggest that TIF1┚ can selectively activate the expression of various 
pluripotency-specific genes in a phosphorylation-dependent manner. 
Biochemical analysis suggests that TIF1┚ functions as a transcriptional activator of 
pluripotency specific genes by forming a complex with pluripotency-specific transcriptional 
factors at promoter regions. Indeed, co-immunoprecipitation assays revealed that TIF1┚ 
specifically forms a complex with Oct4 in a C-terminal phosphorylation-dependent manner. 
In contrast, another pluripotency-specific transcription factor, Sox2, was not detected in this 
complex. In addition to these transcription factors, Smarcd1/BAF60a was found to interact 
with TIF1┚, although this interaction was not dependent on the phosphorylation of TIF1┚. 
As mentioned above, our quantitative proteomic analysis has previously identified Smarcd1 
as a highly expressed protein in undifferentiated ES cells (Kurisaki, et al., 2005). Smarcd1 
functions as an ATP-dependent SWI/SNF chromatin remodeling factor that modulates 
chromatin structure. Recently, Smarcd1 has been shown to be a component of esBAF, an ES-
specific BAF (Brg/Brahma–associated factors) ATP-dependent chromatin remodeling 
complex, which is essential for ES cell self-renewal and pluripotency (Ho, et al., 2009). 
Endogenous TIF1┚ also formed a complex with other esBAF components, such as Brg-1 and 
BAF155. TIF1┚-S824D specifically induced transcriptional activation of a proximal Nanog 
promoter reporter construct with Oct4. A ChIP assay confirmed that TIF1┚ forms a complex 
on the endogenous Nanog promoter in a phosphorylation-dependent manner. TIF1┚-S824D 
was shown to recruit endogenous Oct4 to form an active complex on the Nanog promoter. 
Microarray analysis revealed that one third of Oct4 target genes are specifically regulated by 
phosphorylated TIF1┚. Several chromatin remodeling factors such as Suz12, Chd9, Pcaf, and 
Smarcad1 were also induced by TIF1┚-S824D. Our data suggest that phosphorylated TIF1┚ 
forms a unique complex with Oct4 on pluripotency-specific genes and promotes expression 
of pluripotency-specific transcriptional factors such as Nanog, Sox2, and Oct4. Recent 
studies by ChIP-ChIP analysis revealed that TIF1┚ interacts with half of the promoters 
occupied by Oct4 and Sox2 (Jin, et al., 2007), suggesting that TIF1┚ might be an important 
regulator of Oct4-dependent transcription in ES cells.  
The SWI/SNF2-like chromatin complex (BAF complex) is a huge complex with ATP-
dependent chromatin remodeling activity, which is about 2 M Da in size. Components in 
this complex, such as Brg-1, BAF155, and BAF47, are essential in early development. Knock-
out mice of these genes lead to peri-implantation lethality and failure to generate both the 
inner cell mass and trophoblast. Brg has been purified from Xenopus egg extracts and 
promoted the reprogramming of somatic cells into ES-like stem cells (Hansis, et al., 2004). 
Ho et al. reported that the ES-specific BAF complex (esBAF), which is required for self-
renewal and pluripotency of mouse ES cells, was different from that in mouse embryonic 
fibroblasts (MEFs) or newborn mouse brain. The esBAF contains Brg-1, BAF155, and 
BAF60a, but not Brm, BAF170, or BAF60c. Pluripotency-specific transcription factors Oct4 
and Sox2 also associated with the esBAF complex (Ho, et al., 2009). Recently, other groups 
have reported that a couple of proteins, which are components of the chromatin remodeling 
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complex, promote the establishment of iPS cells from MEFs (Singhal, et al., 2010). They 
performed differential proteomics of the nuclear proteins extracted from NIH3T3 cells and 
F9 embryonic carcinoma cells by SILAC method. After computer-assisted Gene Ontology 
analysis of more than 5,000 identified proteins, they found specific expression of chromatin 
remodelling factors in pluripotent ES cell. Among them, Brg-1 and BAF155, which have 
been suggested to be crucial factors for maintenance of pluripotency of ES cells, promoted 
demethylation of pluripotency-specific transcription factor promoters such as the Oct4 and 
Nanog locus during the induction of iPS cells. Their results also supported the importance 
of the chromatin remodeling protein complex for the establishment of iPS cells from somatic 
cells. 
5. Interactome of transcription factors identified by proteomics 
In addition to describing a total set of proteins expressed in a population, proteomics are 
quite powerful for the analysis of protein components in a certain complex. Identification of 
functional protein complexes of transcription factors is important to elucidate transcription 
networks. Wang et al. constructed a protein interaction network surrounding the 
pluripotency factor Nanog (Wang, et al., 2006) by taking advantage of unique ES cells that 
express Escherichia coli biotin ligase, BirA. In this ES cell line, Nanog protein was N-
terminally tagged with Flag and a biotin acceptor sequence was biotinylated in vivo. Thus, 
the Nanog protein complex was readily isolated by tandem purification with Flag antibody 
beads and streptavidin beads. In total, 266 proteins were identified. The constructed 
network was enriched for nuclear factors important for maintenance of the ES cell state and 
co-regulation of differentiation. Recently, an extended protein network that interacts with 
Oct4 was also reported using a different epitope-tagging affinity purification strategy 
(Pardo, et al., van den Berg, et al., 2010). A combination of the 3× FLAG epitope and a 
calmodulin binding peptide (CBP) separated by a TEV cleavage site was inserted into the C-
terminus of the Oct4 coding region of a BAC clone containing full-length Oct4. This BAC 
construct was then integrated into the Hprt locus of mouse ES cells. In this system, 
expression levels of the Oct4-fusion protein were less than that of endogenous Oct4. In 
another study, van den Berg et al. used a single N-terminally 3× FLAG epitope-tagged Oct4 
as the probe. Both studies succeeded in describing a detailed Oct4-centered interactome 
network in mouse ES cells. Although Oct4, Sox2, and Nanog form a positive feedback loop 
to maintain the ES cell-specific transcription network, such protein interactomes constructed 
by proteomics helps to locate Oct4 networks in known signaling pathways. Interestingly, 
both studies identified chromatin-related proteins, such as SWI/SNF chromatin remodelling 
factors, the NuRD complex, and the LSD1 complex, rather than pluripotency-enriched 
transcription factors. These results suggest the importance of epigenetic modifying complex 
associated with transcription factors in ES cells. 
6. Application of pluripotent stem cells for regenerative medicine 
Recently developed iPS cell technology enabled to obtain patient-derived pluripotent stem 
cells by reprogramming adult somatic cells with four transcription factors that can 
reorganize the ES-like transcription network (Takahashi, et al., 2007). Although iPS 
technology can overcome two critical problems, such as immunorejection due to mismatch 
of HLA types and ethical issues associated with using ES cells established from destroyed 
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human embryos, there are still many problems that need to be addressed. First, these stem 
cells are not standardized; not all pluripotent stem cells can efficiently differentiate into 
specific cells. Moreover, insufficient differentiation methodologies for stem cells pose an 
increasing problem. Differentiation of pluripotent stem cells has been mainly studied with 
mouse and human ES cells. However, the specificity and efficiency of differentiation of these 
stem cells by current methods is still insufficient. Moreover, most of the differentiated cells 
are embryonic-type cells, not adult-type, and may not effectively function in patients. 
Therefore, in addition to establishing quantitative and specific differentiation methods, 
maturation protocols for differentiated cells may be required to obtain the targeting cells in 
vitro.  
One of the most serious concerns for their application to regenerative medicine is the 
tumorigenic property of iPS cells. After transplantation of differentiated cells derived from 
iPS cells, occasionally teratomas can form from transplanted cells. Two major reasons have 
been suggested for this phenomenon. One is due to reactivation of the integrated 
tumorigenic transgene c-Myc in iPS cells. Human iPS cells have been established by the 
stable introduction of crucial transcription factors, Oct4, Sox2, Klf4, and c-Myc into the 
genome using retroviral or lentiviral gene transfer. Induction of iPS cells from fibroblasts 
would be much less efficient if c-Myc was excluded. However, genomic incorporation of 
transgenes by these viruses itself destroys multiple loci of the endogenous genome, which 
increases the potential risk of tumor formation by disruption of tumor suppression genes. 
Recently developed alternative integration-free induction methods, such as protein (Kim, et 
al., 2009, Zhou, et al., 2009), RNA (Fusaki, et al., 2009, Nishimura, et al., 2011, Warren, et al., 
2010), and chemical compound-based induction methods (Li, et al., 2009) are expected to 
overcome this problem. In addition to reactivation of the Myc transgene during 
differentiation, residual contamination of undifferentiated iPS cells in the differentiated cell 
population may also lead to tumor formation (Nakagawa, et al., 2008). Transplantation of 
pluripotent ES cells into immunodeficient mice by definition generates teratomas in vivo that 
contain tridermically differentiated tissues. For the differentiation of both human and mouse 
ES/iPS cells, an embryoid body-based method has been widely adopted. Differentiation by 
embryoid body formation is an effective and convenient method for ES/iPS cell 
differentiation. However, there could be some residual differentiation-resistant pluripotent 
stem cells inside the embryoid body, and these stem cells may continue to grow after 
transplantation into the patient. Therefore, contamination of a small number of pluripotent 
stem cells causes high risk of tumor formation after transplantation (Miura, et al., 2009). 
7. Tumorigenicity of pluripotent stem cells 
To avoid tumor formation caused by contamination of undifferentiated stem cells, some 
approaches have been proposed. For example, prolonged in vitro differentiation of human 
ES cells into dopaminergic neurons is effective for preventing the formation of teratomas 
(Brederlau, et al., 2006). Another example is the control of stem cell fate by “stem cell suicide 
genes”. Stable introduction of a suicide gene such as the herpes simplex virus thymidine 
kinase gene has been reported (Schuldiner, et al., 2003), which makes ES cells highly 
sensitive to ganciclovir at low concentrations. The expression of thymidine kinase under the 
control of the Oct4 promotor is effective for the ablation of undifferentiated ES cells in vivo 
that may produce teratomas (Hara, et al., 2008). However, the long-term stability of 
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exogenous suicide genes in vivo has yet to be evaluated. An alternative approach is 
separation of residual pluripotent stem cells by cell-surface markers. Several cell-surface 
markers specific to pluripotent ES/iPS cells, such as SSEA4, TRA-1-60, and TRA-1-81, have 
been widely used. SSEA-4 is a glycolipid carbohydrate epitope specifically detected in 
human ES/iPS/EC cells. SSEA-4 is also expressed in some populations of mesenchymal 
stem cells (Gang, et al., 2007) and spermatogonial cells (Conrad, et al., 2008). Both TRA-1-60 
and TRA-1-81 are antigens that are carbohydrate chains of a pericellular matrix 
proteoglycan, podocalyxin. They were first identified as cell-surface markers expressed in 
embryonic carcinomas. TRA-1 family proteins are specifically expressed both in human and 
rodent ES/iPS cells. However, these antigens can be lost by digestion of proteoglycan 
peptide with trypsin or collagenase treatment, which is required for dissociation of cells 
after differentiation. Podocalyxin without glycosylation is no longer a pluripotency-specific 
marker. On the other hand, insufficient dissociation of differentiated cell mixtures in 
embryoid bodies could increase the risk of contamination of undifferentiated cells that cause 
uncontrolled growth and teratoma formation after transplantation. Thus, efficient and 
complete removal of residual ES/iPS cells seems to be important for transplantation of 
differentiated cells. Mouse and human ES cells are considerably different from each other 
with respect to growth factor requirements and cell surface markers. Recent reports have 
suggested that human ES cells are somewhat similar to mouse Epi-stem cells (Epi-SC). 
Human ES/iPS cells have difficulty surviving after complete dissociation by proteases 
without a ROCK inhibitor (Watanabe, et al., 2007), and their growth rate is relatively slow. 
This property of human pluripotent stem cells might be helpful to lower the risk of teratoma 
formation after transplantation of differentiated cells. However, recently developed culture 
conditions for human ES cells (Hanna, et al., 2010) may allow easier handling of human 
ES/iPS cells as mouse ES cells and concomitantly increase the danger of tumor formation. 
8. Proteomics approaches to identify cell-surface markers in pluripotent stem 
cells 
Protein analyses by comprehensive proteomics are a potent strategy to elucidate not only 
identification of marker proteins, but also the molecular dynamics of proteins and their 
biological implications in cells and tissues. In particular, approximately 20-30% of vertebrate 
genes encode integral membrane proteins, and especially cell-surface membrane proteins 
are involved in critical cellular processes and are considered major pharmaceutical drug 
targets. Despite their biological significance and benefits as cell-surface markers, proteomic 
analysis of membrane proteins has technical challenges because of their relatively higher 
molecular weight and hydrophobicity. 2D-PAGE in combination with multicolor fluorescent 
labeling of proteins for quantitative analysis has limitations in terms of the dynamic range of 
protein quantity and the molecular mass range of detectable proteins. In addition, 
difficulties in fully automating 2D-PAGE coupled with MS have hampered its widespread 
use for large-scale proteomic analysis. Shotgun-based techniques that digest protein samples 
into small peptides prior to MS analysis have recently been developed for high-throughput 
proteomic analysis. Protease treatment of protein extracts generates a huge number of 
peptides. Therefore, a digested peptide mixture should be well fractionated and 
concentrated for efficient protein identification with low background noise. We have 
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previously reported an improved method for MALDI-TOF based proteomic analysis of 
membrane proteins with a combination of zwitterionic hydrophilic interaction liquid 
chromatography and reverse-phase chromatography, which is a more effective separation 
method for digested peptide mixtures (Intoh, et al., 2009a). Using this method, we have 
performed proteomic analysis of membrane proteins specifically expressed in pluripotent 
mouse ES cells. For quantitative comparison, we used isobaric tags reagents, iTRAQ,  
 
 
 
 
 
 
 
 
Fig. 4. Safe regenerative medicine using differentiated cells without contamination of tumor-
forming pluripotent stem cells. The iPS cells established from patients are processed to 
differentiate into target cells. However, contamination of a small number of differentiation-
resistant pluripotent stem cells in the differentiated cell pool can result in teratoma 
formation. Pluripotency-specific cell-surface markers may be useful to remove residual 
pluripotent iPS cells from the differentiated cell pool before transplantation.  
www.intechopen.com
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
154 
to label trypsinized peptides prepared from different cell sources. Simultaneously, we also 
tested the conventional 2D-PAGE method for identification of membrane proteins for 
comparison, where extracted proteins were labeled with different fluorescent dyes, 
combined, and separated by 2D-PAGE. As such, we identified various candidate proteins 
that are highly expressed on the plasma membrane of pluripotent ES cells and significantly 
down-regulated during differentiation (Intoh, et al., 2009b). Some of the identified cell-
surface proteins were also highly expressed in human ES/iPS cells and down-regulated 
during differentiation via embryoid body formation. These highly expressed membrane 
proteins could be useful for separation of residual ES/iPS cells from in vitro differentiated 
cell mixtures. The ultimate goals of safe regenerative medicine using human pluripotent 
stem cells require purification of targeting progenitors or differentiated cells. They also 
request complete removal of residual pluripotent stem cells, which could continue to grow 
and form teratomas in vivo. Development of more efficient differentiation methods as well 
as identification of specific cell-surface markers for both pluripotent and differentiated cells 
will contribute to safe and effective regenerative medicine in the near future (Fig. 4). 
9. Conclusion 
In this chapter, we have introduced some examples of proteomic analysis of ES cells. 
Transcriptome analysis using microarrays or direct sequencing of transcripts reveals the 
expression of mRNAs. However, the transcriptome does not necessarily correlate with 
expression levels of the corresponding protein. Moreover, analysis of the protein 
interactome by proteomics provides significant insight into understanding the mechanisms 
of how transcription factors function to establish pluripotency-specific functions in ES cells. 
Thus, proteomics approaches are important for further understanding the regulatory 
mechanisms of pluripotency and differentiation of ES/iPS cells.  
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